Detailed ExplanationNLE · Endocrine & Metabolic NursingReal content

NLE Endocrine & Metabolic Nursing — Diabetes Mellitus & Its ComplicationsDetailed Explanation

Summary Concepts Notes Revision Deep Dive Slides Flashcards Mistakes Cheat Mnemonics Templates

This is the "office hours" version of Diabetes Mellitus & Its Complications for the NLE 2026. No shortcuts, no hand-waving — just a full unpacking of why Professional Regulation Commission (PRC) — Board of Nursing cares about each concept and how the Endocrine & Metabolic Nursing section items tend to play out on exam day. Read this once, then hit the practice questions with real understanding.

Exam context

The Philippine Nurse Licensure Examination (PNLE) is conducted by Professional Regulation Commission (PRC) — Board of Nursing and is scheduled for Bi-annual. The Endocrine & Metabolic Nursing subtest is marked as "Core" in the official pattern, and Diabetes Mellitus & Its Complications appears in position 3rd of 3 in the NLE Endocrine & Metabolic Nursing review rotation. Passing mark: 75% weighted average with no sub-test below 60%. Recent NLE 2026 papers have drawn roughly 50 questions from this subject.

Diabetes Mellitus & Its Complications - Detailed Explanation

Diabetes Mellitus (DM) is one of the most heavily tested topics in the Philippine Nursing Licensure Examination (NLE) under Endocrine and Metabolic Nursing. As a BSN graduate, you must master not only the pathophysiology and clinical manifestations, but also the nursing process — from assessment to evaluation — and the life-threatening complications that require immediate, prioritized nursing action. In the Philippine healthcare context, diabetes is a major public health burden, with millions of Filipinos affected. Under RA 9173 (Philippine Nursing Act of 2002), nurses are accountable for safe, competent, and evidence-based care, which means you must apply clinical judgment grounded in sound knowledge. This chapter covers Type 1 and Type 2 DM, insulin pharmacology (the single most tested subtopic), oral hypoglycemic agents, acute emergencies (hypoglycemia, DKA, HHNS), chronic complications, and patient education. Mastery of these concepts will not only help you pass the NLE but will equip you to protect your future patients from preventable harm.

Concepts

Pathophysiology and Classification of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia — elevated blood glucose — resulting from defects in insulin secretion, insulin action, or both. To understand DM, first understand the role of insulin: it is produced by the beta cells of the islets of Langerhans in the pancreas, and its main job is to act like a 'key' that unlocks cells so glucose can enter and be used for energy. Without effective insulin, glucose accumulates in the bloodstream (hyperglycemia) while cells are starved of fuel — a state of 'starvation in the midst of plenty.' Type 1 DM is an autoimmune disease. The body's immune system mistakenly destroys the beta cells, leading to ABSOLUTE insulin deficiency — the pancreas produces little to no insulin at all. This type typically presents in younger, leaner individuals, but it can occur at any age. Because there is no insulin, fat is broken down as an alternative fuel source, producing ketone bodies as a byproduct, which leads to the dreaded complication of Diabetic Ketoacidosis (DKA). Type 1 patients ALWAYS require exogenous insulin — oral agents alone are never appropriate. Type 2 DM is characterized by INSULIN RESISTANCE (cells do not respond normally to insulin) combined with a RELATIVE insulin deficiency (the pancreas cannot produce enough insulin to overcome the resistance). This type is associated with obesity, sedentary lifestyle, and older age, though it is increasingly seen in younger Filipinos due to dietary shifts. Because some insulin is still present, ketone production is usually suppressed, making DKA rare in Type 2 — but these patients are prone to Hyperglycemic Hyperosmolar Nonketotic Syndrome (HHNS). Management ranges from lifestyle modification to oral agents to insulin. Gestational DM occurs during pregnancy when glucose intolerance is first recognized — this is covered in maternal-newborn nursing but is relevant here as a risk factor for future Type 2 DM. The CLASSIC TRIAD of DM symptoms — the '3 Ps' — is: Polyuria (frequent urination due to osmotic diuresis as glucose spills into the urine pulling water with it), Polydipsia (excessive thirst due to fluid loss), and Polyphagia (excessive hunger because cells cannot use glucose). Additional signs include unexplained weight loss (especially Type 1, as the body catabolizes fat and protein), fatigue, blurred vision, and slow-healing wounds or recurrent infections (hyperglycemia impairs immune function and wound healing).

Examples

The young age, lean body habitus, sudden onset of the 3 Ps, and significant weight loss point to Type 1 DM with absolute insulin deficiency. In the Philippine school-based setting, the nurse should document findings, perform point-of-care glucose testing if available, and arrange urgent referral. This is an NLE-favorite scenario because it tests classification knowledge.

Scenario

A 14-year-old student is brought to the school clinic by his teacher. He has been drinking water excessively, urinating frequently, and has lost 5 kg over the past 3 weeks despite eating a lot. He appears thin and fatigued.

Solution

This presentation is consistent with Type 1 Diabetes Mellitus. The nurse should assess blood glucose immediately and notify the physician. The classic 3 Ps are present (polydipsia, polyuria, polyphagia), along with weight loss and fatigue in a young, thin individual.

Older age, obesity, gradual onset, blurred vision, and poor wound healing are hallmarks of Type 2 DM. In the Philippine public health context (PhilHealth-covered services at RHUs), nurses play a pivotal role in early detection and diabetes education. The fasting glucose of 180 mg/dL is above the diagnostic threshold of 126 mg/dL, warranting follow-up.

Scenario

A 58-year-old obese Filipino woman with a sedentary lifestyle presents at the rural health unit (RHU) complaining of fatigue, blurred vision, and a wound on her foot that has not healed for 2 months. Fasting blood glucose is 180 mg/dL.

Solution

This is consistent with Type 2 DM, likely long-standing and previously undiagnosed. The nurse should complete a focused assessment, document the wound characteristics, educate the patient on the significance of the elevated glucose, and facilitate physician referral for diagnosis and management.

Applications

Assess every patient for DM risk factors (obesity, family history, hypertension) during health history taking — standard nursing assessment per NCM 100/101 frameworks.
In community/public health settings (NCM 104), nurses conduct diabetic screening programs and educate high-risk Filipinos (e.g., those with family history, obesity, or gestational DM history).
Apply Maslow's Hierarchy: physiologic needs (glucose regulation, hydration) are priority before psychosocial concerns.
Use NANDA nursing diagnoses: 'Imbalanced Nutrition: Less Than Body Requirements' and 'Risk for Unstable Blood Glucose Level' are relevant in newly diagnosed DM.
Under RA 9173, nurses must perform accurate assessment and documentation; incorrect classification (confusing Type 1 with Type 2) can lead to dangerous medication errors.

Misconceptions

MISCONCEPTION: 'Type 2 DM patients never need insulin.' TRUTH: Many Type 2 patients eventually require insulin as the disease progresses and oral agents become insufficient.
MISCONCEPTION: 'Only overweight people get diabetes.' TRUTH: Type 1 DM typically affects lean individuals; Type 2 is also rising in normal-weight Filipinos with poor diet and sedentary lifestyles.
MISCONCEPTION: 'A single elevated blood glucose reading confirms diabetes.' TRUTH: Diagnosis requires confirmation — either two abnormal fasting values, a fasting + OGTT, or HbA1c ≥6.5% (except when symptoms + random glucose ≥200 is present).
MISCONCEPTION: 'Polyphagia means the patient is absorbing too much food.' TRUTH: Polyphagia occurs because cells cannot use glucose (they are starving), sending hunger signals to the brain.

Related Concepts

Insulin pharmacology and administration
Diabetic Ketoacidosis (DKA)
Hyperglycemic Hyperosmolar Nonketotic Syndrome (HHNS)
Chronic diabetic complications (micro- and macrovascular)
Oral hypoglycemic agents
HbA1c monitoring and glycemic control

Common Exam Questions

Example

Which type of DM results from autoimmune destruction of pancreatic beta cells? Answer: Type 1 DM.

Approach

Look for age, weight/body type, onset speed, and whether ketones are mentioned. Young + lean + ketones = Type 1. Older + overweight + no ketones = Type 2.

Question Type

Identification/Classification

Example

A patient reports drinking 5–6 liters of water daily, urinating frequently, and feeling very hungry despite eating well. The nurse recognizes these as signs of: Answer — Diabetes Mellitus (the 3 Ps: polydipsia, polyuria, polyphagia).

Approach

The NLE often presents a clinical vignette and asks you to identify the most likely condition. Look for the 3 Ps plus associated features (weight loss, age, body type).

Question Type

Clinical Manifestation Recognition

Example

A fasting blood glucose of 130 mg/dL on two separate occasions is diagnostic of: Answer — Diabetes Mellitus (≥126 mg/dL).

Approach

Memorize the exact cutoffs: fasting ≥126, random ≥200 with symptoms, HbA1c ≥6.5%, OGTT 2-hr ≥200.

Question Type

Diagnostic Value Recall

Key Points To Remember

Type 1 DM: autoimmune, absolute insulin deficiency, younger/lean, prone to DKA, ALWAYS needs insulin — never oral agents alone.
Type 2 DM: insulin resistance + relative deficiency, older/overweight, prone to HHNS, managed with diet, oral agents, and eventually insulin.
The 3 Ps: Polyuria, Polydipsia, Polyphagia — the classic triad for any DM type.
Hyperglycemia leads to osmotic diuresis (glucose in urine pulls water out), causing polyuria, dehydration, and polydipsia.
Cells starving despite high blood glucose → polyphagia, fatigue, and weight loss.
Impaired immune function from hyperglycemia → slow healing, recurrent infections (a common NLE clinical scenario).
Diagnostic fasting glucose ≥126 mg/dL (confirmed on 2 separate occasions), random glucose ≥200 mg/dL with symptoms, 2-hr OGTT ≥200 mg/dL, or HbA1c ≥6.5%.

Insulin Pharmacology — Types, Onset, Peak, Duration

Insulin pharmacology is THE single most tested subtopic in the NLE Endocrine unit. You must memorize the four categories of insulin, their onset, PEAK, and duration — because the PEAK is when the patient is at the HIGHEST RISK for hypoglycemia, and this knowledge directly guides safe nursing care (scheduling meals, monitoring, patient teaching). The four categories are: 1. RAPID-ACTING insulin (e.g., lispro/Humalog, aspart/NovoLog, glulisine/Apidra): Onset ~15 minutes, Peak ~30 minutes to 1.5 hours, Duration 3–4 hours. Appearance: CLEAR. This insulin acts very quickly, so it must be given WITH the meal or just before eating — food must already be in front of the patient. If the meal is delayed and this insulin has been given, hypoglycemia is imminent. 2. SHORT-ACTING insulin (Regular insulin, e.g., Humulin R): Onset 30 minutes to 1 hour, Peak 2–4 hours, Duration 5–8 hours. Appearance: CLEAR. Regular insulin is the ONLY type given intravenously (IV) — critical for DKA/HHNS drips. It is given 30 minutes BEFORE a meal. 3. INTERMEDIATE-ACTING insulin (NPH/Neutral Protamine Hagedorn, e.g., Humulin N): Onset 1–2 hours, Peak 6–12 hours, Duration 12–18 hours. Appearance: CLOUDY. NPH is the only cloudy insulin — it must be ROLLED (not shaken) to mix the suspension. Its peak at 6–12 hours means the patient is at hypoglycemia risk several hours after injection — typically during the night if given before bedtime. Do not confuse NPH's cloudiness with 'contaminated' insulin. 4. LONG-ACTING insulin (glargine/Lantus, detemir/Levemir): Onset ~1 hour, Peak: PEAKLESS (no pronounced peak), Duration ~24 hours. Appearance: CLEAR. Provides steady 'basal' insulin coverage without a peak, reducing hypoglycemia risk. Glargine CANNOT be mixed with any other insulin — it has a unique pH (acidic) that is incompatible with other insulins and will cause it to precipitate. It is given once daily, typically at bedtime. CRITICAL NURSING RULES FOR INSULIN ADMINISTRATION: MIXING INSULINS — 'Clear before Cloudy' (Regular before NPH): When mixing regular and NPH insulin in one syringe, the correct sequence is: (1) Inject air into the NPH (cloudy) vial, (2) Inject air into the regular (clear) vial, (3) Withdraw the regular (clear) insulin first, (4) Withdraw the NPH (cloudy) insulin. This prevents contaminating the regular insulin vial with NPH (which could affect future doses). A common memory aid: 'Air into NPH first, draw clear (regular) first.' INJECTION SITES: Rotate sites within the same anatomical area (not randomly across all areas) to ensure consistent absorption. The ABDOMEN is the preferred site — fastest and most consistent absorption. Other sites: thigh (slower), upper arm, and buttock (slowest). Lipohypertrophy (fatty lumps) develops from repeated injections in the same exact spot and impairs absorption — inspect and rotate properly. STORAGE: Opened/in-use insulin vials may be kept at room temperature (for up to 28–30 days depending on type). Unopened vials are refrigerated (NOT frozen — freezing denatures insulin). Warm to room temperature before use for comfort and absorption consistency.

Examples

This sequence — 'clear before cloudy,' with air into NPH vial first — prevents NPH from contaminating the regular insulin vial. If NPH accidentally gets into the regular vial, future doses of 'regular' would contain NPH, causing delayed action and potential hypoglycemia. This is a classic NLE procedural question.

Scenario

A nurse is preparing a patient's morning insulin: 10 units of NPH and 5 units of Regular insulin to be mixed in one syringe. Describe the correct procedure.

Solution

Step 1: Inject 10 units of AIR into the NPH (cloudy) vial (do not draw insulin yet — just air). Step 2: Inject 5 units of AIR into the Regular (clear) vial. Step 3: Withdraw 5 units of REGULAR (clear) insulin. Step 4: Withdraw 10 units of NPH (cloudy) insulin. Total = 15 units in the syringe.

Knowing the insulin peak allows the nurse to proactively schedule meals, snacks, and glucose monitoring. This prevents hypoglycemia, which is a life-threatening complication and a priority nursing concern. This type of calculation-based clinical application is frequently tested in the NLE.

Scenario

A patient received NPH insulin at 7:00 AM. The nurse plans care and anticipates when this patient is at highest risk for hypoglycemia.

Solution

NPH peaks at 6–12 hours after administration. If given at 7:00 AM, the peak effect (and highest hypoglycemia risk) is from 1:00 PM to 7:00 PM. The nurse should ensure the patient eats lunch and afternoon snacks during this window and monitor for hypoglycemia signs.

Patient teaching is a core nursing role under RA 9173. Glargine has an acidic pH that is incompatible with other insulins — mixing causes it to precipitate, losing its 24-hour peakless effect. In NLE scenarios, questions may ask which insulin cannot be mixed or which is given once daily at bedtime.

Scenario

A patient asks why her doctor prescribed glargine insulin and why she cannot mix it with her regular insulin in the same syringe.

Solution

The nurse explains: 'Your glargine insulin provides steady, round-the-clock glucose control without causing peaks that could make your blood sugar drop suddenly. It cannot be mixed with other insulins because of a difference in their chemical makeup — mixing them would cause the medication to clump and become less effective.'

Applications

Always check the patient's meal tray status BEFORE giving rapid-acting insulin — if the meal is unavailable or delayed, withhold the insulin and notify the physician.
Schedule glucose monitoring around insulin peaks (e.g., check glucose 1–2 hours after regular insulin, 6–8 hours after NPH).
Teach patients to inspect injection sites for lipohypertrophy at every clinic visit and reinforce proper rotation technique.
In hospital settings, regular insulin via continuous IV infusion is standard management for DKA/HHNS — prepare insulin drips using ONLY regular insulin.
Apply NANDA nursing diagnosis 'Risk for Unstable Blood Glucose Level' and 'Deficient Knowledge' when planning insulin teaching for newly diagnosed patients.
Under PhilHealth's Z-benefit package for diabetes, insulin is part of the management protocol — nurses in Philippine public hospitals must be competent in insulin administration and teaching.

Misconceptions

MISCONCEPTION: 'Any insulin can be given intravenously.' TRUTH: ONLY regular (short-acting) insulin is given IV. Giving NPH or long-acting insulin IV is dangerous and incorrect.
MISCONCEPTION: 'NPH should be shaken vigorously to mix it.' TRUTH: NPH should be GENTLY ROLLED between the palms — shaking creates air bubbles and can damage the insulin protein, altering its effect.
MISCONCEPTION: 'Glargine is cloudy because it is long-acting.' TRUTH: Glargine is CLEAR. Only NPH is cloudy among the common insulins. This distinction is heavily tested.
MISCONCEPTION: 'Rotating to different body sites every injection gives better results.' TRUTH: Rotate within ONE anatomical area (e.g., always in the abdomen, rotating spots within the abdomen) for consistent absorption. Random site rotation causes unpredictable absorption.
MISCONCEPTION: 'Long-acting insulin peaks cause nighttime hypoglycemia.' TRUTH: Glargine and detemir are PEAKLESS — they do not have a pronounced peak, which is why they are preferred for basal coverage. Nighttime hypoglycemia is more associated with NPH (intermediate-acting).

Related Concepts

Hypoglycemia management (insulin peak awareness)
DKA management (IV regular insulin drip)
Mixing insulin technique (nursing procedure)
Lipohypertrophy prevention (injection site rotation)
Patient education on self-injection technique

Common Exam Questions

Example

Which insulin preparation appears cloudy and must be gently rolled before use? Answer: NPH (intermediate-acting) insulin.

Approach

Match the appearance (clear/cloudy), timing, and specific drug name to the category. NPH = cloudy = intermediate. Glargine = clear = peakless = long-acting. Regular = clear = IV-capable.

Question Type

Identification of Insulin Type

Example

A patient about to receive insulin lispro reports feeling too nauseated to eat. The nurse's best action is: withhold the dose and notify the physician.

Approach

Rapid-acting insulin requires food to be available. If a patient cannot eat (NPO, nausea, delayed meal tray), the nurse should withhold the rapid-acting insulin and consult the physician.

Question Type

Prioritization — When to Withhold Insulin

Example

When mixing NPH and regular insulin, what is the FIRST step? Answer: Inject air into the NPH vial (cloudy vial first).

Approach

Remember: 'Air into NPH first, draw clear (regular) first.' The NLE may present steps out of order and ask you to identify the correct sequence.

Question Type

Mixing Sequence (Procedural)

Example

A patient receives NPH insulin at 10 PM. When should the nurse be most alert for hypoglycemia? Answer: Between 4 AM and 10 AM (peak at 6–12 hours after administration).

Approach

Add the onset time to the peak range. NPH given at bedtime (10 PM) peaks at 4–10 AM — nighttime hypoglycemia risk.

Question Type

Identifying Hypoglycemia Risk Window

Key Points To Remember

Rapid-acting (lispro, aspart): onset 15 min, peak 30 min–1.5 hr, duration 3–4 hr, CLEAR — give WITH meal.
Short-acting (Regular): onset 30 min–1 hr, peak 2–4 hr, duration 5–8 hr, CLEAR — give 30 min BEFORE meal; ONLY insulin given IV.
Intermediate (NPH): onset 1–2 hr, peak 6–12 hr, duration 12–18 hr, CLOUDY — roll to mix, do NOT shake.
Long-acting (glargine, detemir): onset ~1 hr, PEAKLESS, duration ~24 hr, CLEAR — NEVER mix with other insulins.
Peak = highest hypoglycemia risk. Regular peaks at 2–4 hr, NPH at 6–12 hr, rapid at 30 min–1.5 hr.
Mixing sequence: Air into NPH → Air into regular → Draw CLEAR (regular) FIRST → Draw CLOUDY (NPH) second.
Abdomen = fastest insulin absorption site; preferred for consistent dosing.
Glargine is NEVER mixed with any other insulin — incompatible pH.

Oral and Non-Insulin Antidiabetic Agents

Oral antidiabetic agents are the cornerstone of Type 2 DM management. The NLE tests these drugs primarily by mechanism of action, key nursing considerations (especially hypoglycemia risk), and important contraindications. You do not need to memorize every drug, but the key classes and their critical nursing implications are essential. BIGUANIDES — METFORMIN (first-line for Type 2 DM): Metformin works by DECREASING hepatic glucose production and IMPROVING insulin sensitivity in the periphery. Key NLE points: (1) It does NOT cause hypoglycemia when used alone (no insulin secretion stimulation), making it safer for outpatient use. (2) Risk of LACTIC ACIDOSIS — especially in patients with renal impairment. (3) MUST be HELD 24–48 hours before AND after any contrast dye (iodinated contrast) procedures (CT scans with contrast, cardiac catheterization, IVP) because contrast can cause acute kidney injury, which impairs metformin excretion and increases lactic acidosis risk. (4) Take with food to minimize GI side effects (nausea, diarrhea). This is a classic Philippine NLE scenario: 'A diabetic patient is scheduled for a CT scan with contrast — what should the nurse do?' Answer: Hold metformin. SULFONYLUREAS — glipizide, glyburide, glimepiride: Stimulate the pancreatic beta cells to secrete MORE insulin, regardless of glucose level. KEY RISK: HYPOGLYCEMIA and weight gain. Use caution with elderly patients (prolonged hypoglycemia risk). Alcohol + sulfonylureas can cause a disulfiram-like reaction (flushing, nausea). Teach patients to eat regularly and not skip meals. MEGLITINIDES — repaglinide, nateglinide: Rapid-onset, short-acting insulin secretagogues. Taken WITH meals (one pill per meal — skip the dose if skipping the meal). HYPOGLYCEMIA risk, but shorter duration means less prolonged episodes. THIAZOLIDINEDIONES (TZDs) — pioglitazone: Improve insulin sensitivity. Key risks: FLUID RETENTION (contraindicated in heart failure), weight gain, and hepatotoxicity (monitor liver function tests). DPP-4 INHIBITORS — sitagliptin (Januvia): Enhance incretin effect (increase insulin, decrease glucagon). Low hypoglycemia risk when used alone. Generally well-tolerated. SGLT2 INHIBITORS — empagliflozin, dapagliflozin (drug names end in '-gliflozin'): Cause renal glucose excretion (block glucose reabsorption in the kidney, so glucose is 'dumped' in the urine). Key risks: GENITAL YEAST INFECTIONS, urinary tract infections, dehydration, and the rare but dangerous EUGLYCEMIC DKA (DKA with normal or near-normal glucose — do not be fooled by a normal glucose!). Cardiovascular and renal protective benefits shown in recent studies. GLP-1 RECEPTOR AGONISTS — liraglutide, semaglutide, exenatide (drug names end in '-tide' or '-glutide'): Injectable agents (not oral, except semaglutide oral). Stimulate insulin release in a glucose-dependent manner, suppress glucagon, delay gastric emptying, and promote weight loss. GI side effects (nausea, vomiting) are common, especially at initiation. Low hypoglycemia risk alone. Cardiovascular protective effects. NURSING PRIORITY: Identify WHICH agents cause hypoglycemia (sulfonylureas, meglitinides, and insulin) versus which do NOT (metformin, TZDs, DPP-4 inhibitors, SGLT2 inhibitors, GLP-1 agonists when used alone).

Examples

Metformin is renally excreted. Contrast dye can cause contrast-induced nephropathy, which reduces metformin clearance → metformin accumulates → lactic acidosis, a life-threatening complication. In this patient with already-compromised renal function (CKD Stage 3), the risk is even higher. This is a HIGH-YIELD NLE scenario.

Scenario

A patient with Type 2 DM and Stage 3 CKD is admitted. His current medications include metformin 500 mg twice daily. The attending physician orders an abdominal CT scan with IV contrast. What is the nurse's priority action?

Solution

The nurse should HOLD the metformin before the contrast procedure AND consult the physician to clarify when to resume it (typically 48 hours post-procedure, after confirming renal function is stable). This is a critical nursing intervention to prevent lactic acidosis.

Sulfonylureas are insulin secretagogues — they force the pancreas to release insulin whether or not glucose is high. If the patient eats less than usual or skips a meal, the extra insulin will cause hypoglycemia. Patient education is a key nursing intervention per RA 9173 standards of nursing practice.

Scenario

A newly diagnosed Type 2 DM patient is started on glipizide. The nurse educates her about the most important side effect to watch for.

Solution

The nurse teaches the patient to watch for signs of hypoglycemia (shakiness, sweating, hunger, palpitations, dizziness) because glipizide stimulates insulin secretion regardless of blood glucose levels. The patient should eat regular meals and never skip food after taking the medication.

Applications

Review a diabetic patient's medication list every shift — identify which agents put them at hypoglycemia risk and adjust meal and glucose monitoring schedules accordingly.
Pre-procedure: Always check if the patient takes metformin before any contrast-enhanced imaging; hold per protocol and document.
Teach SGLT2 inhibitor patients about genital hygiene to prevent yeast infections and to recognize symptoms of DKA even with 'normal' glucose.
Apply NANDA 'Deficient Knowledge' and 'Risk for Injury' (hypoglycemia) when planning care for patients on sulfonylureas.
In Philippine community settings, many Type 2 DM patients self-manage with oral agents — community nurses (NCM 104) must assess medication adherence, storage, and side effects during home visits.

Misconceptions

MISCONCEPTION: 'Metformin lowers blood sugar by making the pancreas produce more insulin.' TRUTH: Metformin reduces hepatic glucose output and improves insulin sensitivity — it does NOT stimulate insulin secretion, which is why it does not cause hypoglycemia alone.
MISCONCEPTION: 'If a patient on SGLT2 inhibitors has a normal blood glucose, they cannot have DKA.' TRUTH: Euglycemic DKA can occur with SGLT2 inhibitors — glucose may be near-normal while ketoacidosis is present. Nurses must assess for symptoms (nausea, abdominal pain, elevated ketones) even with acceptable glucose readings.
MISCONCEPTION: 'All antidiabetic pills work the same way.' TRUTH: Each class has a distinct mechanism, side effect profile, and contraindications — knowing the differences is essential for safe nursing practice and NLE success.
MISCONCEPTION: 'TZDs are safe for all Type 2 DM patients.' TRUTH: TZDs (pioglitazone) are contraindicated in heart failure due to fluid retention, and require monitoring for hepatotoxicity.

Related Concepts

Hypoglycemia management
Renal function monitoring in diabetes
Patient education for medication adherence
DKA (including euglycemic DKA from SGLT2 inhibitors)
Nursing considerations for preoperative diabetic patients

Common Exam Questions

Example

A patient taking pioglitazone develops bilateral leg edema and dyspnea. The nurse should recognize this as: fluid retention — a known side effect of TZDs, potentially indicating heart failure exacerbation.

Approach

Know the key contraindications: metformin + contrast dye or renal failure; TZDs + heart failure; sulfonylureas + skipped meals.

Question Type

Drug-Contraindication Matching

Example

Which oral diabetic medication, when used as monotherapy, carries the highest risk of hypoglycemia? Answer: Sulfonylurea (e.g., glipizide, glyburide).

Approach

Only agents that stimulate insulin secretion (sulfonylureas, meglitinides) or exogenous insulin cause hypoglycemia when used alone. Metformin alone does NOT.

Question Type

Hypoglycemia Risk Identification

Example

Before a colonoscopy requiring NPO status and bowel prep, which medication should the nurse HOLD and NOT administer? Answer: Metformin (and clarify insulin orders — typically hold or reduce dose during NPO).

Approach

Preoperative and pre-procedure checklist for diabetic patients: hold metformin, clarify insulin orders (typically reduce dose for NPO patients), monitor glucose.

Question Type

Priority Action Before Procedure

Key Points To Remember

Metformin: first-line Type 2 DM, NO hypoglycemia alone, HOLD before/after contrast dye, risk of lactic acidosis in renal impairment, take with food.
Sulfonylureas (glipizide, glyburide): stimulate insulin secretion → HYPOGLYCEMIA risk, weight gain, disulfiram reaction with alcohol.
Meglitinides (repaglinide): take WITH meals, skip dose if skipping meal, short-acting hypoglycemia risk.
TZDs (pioglitazone): fluid retention — AVOID in heart failure; hepatotoxicity — monitor LFTs.
SGLT2 inhibitors (-gliflozin): glucose in urine → genital/urinary infections, euglycemic DKA risk.
GLP-1 agonists (-tide, -glutide): injectable, promotes weight loss, GI side effects (nausea), low solo hypoglycemia risk.
Hypoglycemia risk agents: sulfonylureas, meglitinides, insulin. Non-hypoglycemia solo agents: metformin, TZDs, DPP-4 inhibitors, SGLT2 inhibitors, GLP-1 agonists.

Hypoglycemia — Assessment, Prioritization, and Management

Hypoglycemia — blood glucose below 70 mg/dL — is the most COMMON acute diabetic emergency and one of the most dangerous. It can progress from mild discomfort to seizures and coma within minutes if untreated. The brain (which cannot store glucose and depends entirely on blood glucose for fuel) is the most vulnerable organ during hypoglycemia. CAUSES: - Too much insulin or oral hypoglycemic agent - Skipped or delayed meals - Excessive physical activity without adjusting food/insulin - Alcohol intake (alcohol inhibits hepatic gluconeogenesis — the liver's ability to release glucose) - Drug interactions CLINICAL MANIFESTATIONS — remember the phrase: 'COLD AND CLAMMY — NEED SOME CANDY': ADRENERGIC/SYMPATHETIC signs (early — body releases epinephrine in response to low glucose): - Shakiness/trembling - Diaphoresis (cold, clammy skin — differentiates from hyperglycemia which causes dry, warm skin) - Tachycardia/palpitations - Anxiety, nervousness - Pallor - Hunger NEUROGLYCOPENIC signs (later — brain glucose deprivation): - Confusion, difficulty concentrating - Slurred speech - Blurred vision - Headache - Personality changes/irritability - Seizures - COMA (most severe) IMPORTANT CONTRAST with HYPERGLYCEMIA skin findings: Hypoglycemia → cold, clammy, diaphoretic skin (from adrenergic response). Hyperglycemia → warm, dry, flushed skin (from dehydration). TREATMENT — THE 'RULE OF 15': IF THE PATIENT IS CONSCIOUS AND CAN SWALLOW: 1. Give 15 grams of FAST-ACTING carbohydrates: - ½ cup (120 mL) of regular (non-diet) fruit juice or soda - 3–4 glucose tablets - 1 tablespoon of honey or sugar (dissolved in water) - 15 small candies (e.g., Mentos) 2. WAIT 15 minutes 3. RECHECK blood glucose 4. If still <70 mg/dL, REPEAT the 15 grams of carbohydrates 5. Once glucose returns to normal, give a LONGER-ACTING snack (e.g., crackers with peanut butter, bread with protein) to prevent recurrence IF THE PATIENT IS UNCONSCIOUS OR UNABLE TO SWALLOW: - NEVER give anything by mouth (aspiration risk — this is a classic NLE wrong-answer trap) - IN-HOSPITAL: Administer IV DEXTROSE 50% (D50W) — 25–50 mL IV push as ordered - OUT-OF-HOSPITAL: Administer GLUCAGON (1 mg IM or subcutaneous) — glucagon stimulates the liver to release glycogen as glucose (requires a functioning liver and glycogen stores) - Position patient safely (side-lying to prevent aspiration if vomiting) - Monitor closely until fully conscious and able to eat Once responsive, oral carbohydrates and a protein-containing snack are given to maintain glucose levels. SOMOGYI PHENOMENON vs. DAWN PHENOMENON (two morning high-glucose scenarios that are heavily tested): Somogyi Phenomenon: Nighttime (nocturnal) HYPOGLYCEMIA → the body releases counter-regulatory hormones (glucagon, epinephrine, cortisol, growth hormone) → REBOUND morning HYPERGLYCEMIA. Diagnosis: check glucose at 2–3 AM — it will be LOW. Treatment: REDUCE evening insulin dose or add a bedtime carbohydrate snack. Dawn Phenomenon: Morning hyperglycemia due to a NORMAL early-morning hormone surge (growth hormone, cortisol) that raises glucose — NO preceding nighttime hypoglycemia. Diagnosis: check glucose at 2–3 AM — it will be NORMAL or ELEVATED. Treatment: INCREASE or ADJUST insulin dose/timing. Memory aid: Somogyi = 'Sneaky Low then High' — nocturnal low causes rebound. Dawn = 'Day starts high naturally.'

Examples

This is a textbook hypoglycemia presentation: glucose <70, cold/clammy skin, shakiness, tachycardia, hunger. The Maslow-based priority is physiologic safety (preventing progression to seizures/coma). The NANDA nursing diagnosis is 'Risk for Unstable Blood Glucose Level' and 'Risk for Injury.' The patient is conscious, so oral glucose is appropriate — IV D50 is reserved for unconscious patients.

Scenario

A hospitalized patient with Type 2 DM on glipizide and insulin calls the nurse because she is feeling 'shaky and very hungry.' On assessment: BP 100/70 mmHg, PR 110 bpm, skin is cold and clammy. Point-of-care glucose reads 58 mg/dL.

Solution

Priority: hypoglycemia intervention. The nurse should immediately give 15 g of fast-acting carbohydrates (e.g., 4 oz of orange juice or 3–4 glucose tablets), reassess in 15 minutes, and recheck glucose. If the patient remains symptomatic or glucose is still <70 after 15 minutes, repeat the process. Once stable, offer a snack containing complex carbohydrates and protein. Document findings and notify the physician.

The key differentiator is the 2–3 AM glucose level: LOW = Somogyi (reduce insulin), NORMAL or HIGH = Dawn phenomenon (adjust/increase insulin). The NLE frequently presents morning hyperglycemia cases and tests whether the candidate can correctly identify Somogyi vs. Dawn based on the midnight glucose value — this is a HIGH-YIELD discrimination point.

Scenario

A patient with Type 1 DM reports waking up with high blood glucose every morning (around 200 mg/dL). The nurse checks his glucose at 2 AM for three consecutive nights and finds values of 52, 48, and 60 mg/dL. What is the likely phenomenon?

Solution

This is the SOMOGYI PHENOMENON. The 2–3 AM glucose values are consistently LOW (<70 mg/dL), followed by rebound morning hyperglycemia from counter-regulatory hormone release. The intervention is to REDUCE the evening insulin dose and/or add a bedtime carbohydrate snack (e.g., a banana or crackers with peanut butter).

Applications

Perform glucose monitoring BEFORE insulin peaks — during NPH's 6–12 hour peak window, check glucose and assess for subtle hypoglycemia signs (confusion, irritability in the elderly may be mistaken for dementia).
Teach diabetic patients and family members the Rule of 15 and how to use a glucagon emergency kit — this is a priority discharge education item.
NEVER leave orange juice or sugary drinks at the bedside of a comatose or semiconscious patient — aspiration is a lethal complication.
Apply NANDA 'Risk for Injury' related to hypoglycemia-induced altered consciousness — implement fall prevention protocols.
During community health visits (NCM 104 context), teach DM families to keep fast-acting glucose sources available at all times and to recognize early hypoglycemia signs in their loved ones.
In Philippine rural settings where glucagon kits may be scarce, educate caregivers on giving glucose via nasogastric tube only if professional guidance is available — home remedies like forcing fluids on unconscious patients are dangerous.

Misconceptions

MISCONCEPTION: 'Give the unconscious hypoglycemic patient juice or sugary drinks by mouth — it is faster.' TRUTH: NEVER give oral fluids to an unconscious patient — aspiration pneumonia can be fatal. IV D50W or IM glucagon are the safe, appropriate treatments.
MISCONCEPTION: 'If a patient is unconscious and their glucose is low, they need insulin.' TRUTH: The opposite — low glucose requires glucose (D50 or glucagon), not insulin. This dangerous confusion is tested on the NLE.
MISCONCEPTION: 'Morning high glucose always means the evening insulin dose should be increased.' TRUTH: If Somogyi phenomenon is causing the morning high (due to rebound from nocturnal hypoglycemia), INCREASING insulin would worsen the nocturnal hypoglycemia. The cause must be identified first by checking the 2–3 AM glucose.
MISCONCEPTION: 'Only patients on insulin get hypoglycemia.' TRUTH: Oral agents that stimulate insulin secretion (sulfonylureas, meglitinides) also cause hypoglycemia — sometimes more prolonged due to their mechanism.

Related Concepts

Insulin pharmacology (peak times predict hypoglycemia risk)
Somogyi phenomenon vs. Dawn phenomenon
Oral hypoglycemic agents (sulfonylureas, meglitinides)
Glucagon administration
Diabetic patient education (Rule of 15)

Common Exam Questions

Example

A patient with DM is found unconscious with a blood glucose of 35 mg/dL. The PRIORITY nursing action is: administer IV D50W as ordered (and nothing by mouth).

Approach

Consciousness status determines the treatment modality. Unconscious = IV D50 or IM glucagon, NOTHING by mouth. This is the most important safety discrimination.

Question Type

Priority Action (Unconscious Hypoglycemic Patient)

Example

A diabetic patient presents with cold, clammy skin, trembling, and a glucose of 60 mg/dL. This presentation is consistent with: Hypoglycemia.

Approach

Skin assessment is the key: cold, clammy = hypoglycemia; warm, dry, flushed = hyperglycemia. Plus glucose values and symptom pattern.

Question Type

Assessment Differentiation (Hypo vs. Hyperglycemia)

Example

A patient has morning hyperglycemia. His 2 AM glucose is 48 mg/dL. This is most consistent with: Somogyi phenomenon. Appropriate intervention: reduce the evening insulin dose.

Approach

Always check the 2–3 AM glucose to differentiate. Low at 2–3 AM = Somogyi (reduce insulin). Normal/high at 2–3 AM = Dawn (increase/adjust insulin).

Question Type

Somogyi vs. Dawn Phenomenon

Key Points To Remember

Hypoglycemia: blood glucose <70 mg/dL — most common acute diabetic emergency.
Early signs (adrenergic): cold, clammy skin, diaphoresis, shakiness, tachycardia, pallor, hunger — 'cold and clammy, need some candy.'
Late signs (neuroglycopenic): confusion, slurred speech, seizures, coma — brain deprived of glucose.
Rule of 15: 15 g fast-acting carbs → wait 15 min → recheck → repeat if still low → give long-acting snack.
Unconscious patient: NEVER give oral fluids — give IV D50W (hospital) or IM glucagon (community/home).
Somogyi: nocturnal LOW → rebound morning HIGH — check 2–3 AM glucose (low) — REDUCE evening insulin.
Dawn: morning HIGH, no nocturnal low — check 2–3 AM glucose (normal/high) — ADJUST/INCREASE insulin.
Hypoglycemia skin: cold, clammy. Hyperglycemia skin: warm, dry — critical assessment differentiator.

Diabetic Ketoacidosis (DKA) vs. Hyperglycemic Hyperosmolar Nonketotic Syndrome (HHNS)

DKA and HHNS are the two most life-threatening acute hyperglycemic emergencies in diabetes. The NLE consistently tests your ability to DISTINGUISH between them and to prioritize MANAGEMENT steps. These conditions share similarities (hyperglycemia, dehydration) but differ dramatically in pathophysiology and severity of certain features. DIABETIC KETOACIDOSIS (DKA): Occurs primarily in TYPE 1 DM (absolute insulin deficiency). Without insulin, cells cannot use glucose, so the body burns FAT as an emergency fuel source. Fat breakdown (lipolysis) produces KETONE BODIES (beta-hydroxybutyrate, acetoacetate, acetone) as byproducts. Excess ketones overwhelm the body's buffering systems → METABOLIC ACIDOSIS (blood pH drops below 7.35). Common triggers: infections, missed insulin doses, illness, surgery, newly diagnosed Type 1 DM. DKA Clinical Features: - Blood glucose: usually >250 mg/dL (commonly 300–600 mg/dL) - KETONEMIA and KETONURIA (positive ketones in blood and urine) - Metabolic ACIDOSIS: pH <7.35, low bicarbonate (<15 mEq/L) - KUSSMAUL RESPIRATIONS: deep, rapid, labored breathing — a compensatory mechanism by which the respiratory system tries to 'blow off' excess CO₂ to raise pH (the body compensates for metabolic acidosis with respiratory alkalosis) - FRUITY (acetone) breath — from exhaled ketones - Nausea, vomiting, abdominal pain - Dehydration (significant) - Altered mental status (confusion, drowsiness) - Onset: HOURS (rapid) HYPERGLYCEMIC HYPEROSMOLAR NONKETOTIC SYNDROME (HHNS/HHS): Occurs primarily in TYPE 2 DM (older, often poorly controlled). There is ENOUGH residual insulin to prevent significant fat breakdown and ketosis, but NOT enough to control glucose. Blood glucose rises to extreme levels over DAYS. The extreme hyperglycemia causes massive osmotic diuresis → PROFOUND dehydration → hyperosmolarity (blood becomes very concentrated). High serum osmolality draws water out of brain cells → severe neurological dysfunction. HHNS Clinical Features: - Blood glucose: VERY HIGH, >600 mg/dL (can exceed 1,000 mg/dL) - NO significant ketones (no ketonemia, no ketonuria) - pH near NORMAL (no significant acidosis) - PROFOUND dehydration (more severe than DKA) - VERY HIGH serum osmolality (>320 mOsm/kg) - Severe neurological manifestations: lethargy, seizures, COMA (more profound than DKA due to hyperosmolarity affecting the brain) - No Kussmaul respirations, no fruity breath - Onset: DAYS (gradual) - HIGHER MORTALITY than DKA MANAGEMENT OF BOTH DKA AND HHNS — SAME PRIORITY ORDER: Step 1 — IV FLUIDS FIRST (PRIORITY #1): 0.9% Normal Saline (isotonic) infused rapidly to correct profound dehydration, restore circulatory volume, and improve tissue perfusion. IV fluids alone lower glucose significantly by diluting blood glucose concentration and improving renal perfusion (allowing glucose excretion). Step 2 — REGULAR INSULIN IV: Continuous IV infusion of REGULAR insulin (only regular insulin is given IV) to lower glucose gradually. The goal is to lower glucose by ~50–75 mg/dL per hour — too rapid a drop risks cerebral edema (especially in children) and hypoglycemia. Step 3 — POTASSIUM REPLACEMENT (THE NLE TRAP): This is the most critical and commonly tested nursing consideration. In both DKA and HHNS, total body potassium is DEPLETED (lost in urine from osmotic diuresis). HOWEVER, at presentation, serum potassium may appear NORMAL or even HIGH because: (1) acidosis causes potassium to shift OUT of cells into the bloodstream (in exchange for hydrogen ions), and (2) lack of insulin means less potassium enters cells. Once you give insulin and fluids, potassium shifts BACK INTO cells (insulin drives K+ into cells), and the serum potassium drops rapidly → HYPOKALEMIA → FATAL CARDIAC ARRHYTHMIAS (ventricular fibrillation, ventricular tachycardia) and cardiac arrest. Therefore: MONITOR potassium and ECG closely. ADD potassium to IV fluids ONCE serum potassium is normal or low AND urine output is adequate (to ensure the kidneys can handle potassium). DO NOT give insulin if serum potassium is critically low (< 3.5 mEq/L) without first replacing it. Step 4 — ADD DEXTROSE when glucose reaches ~200–250 mg/dL: Switch IV fluid to D5NS or D5 0.45% NaCl. This allows the insulin drip to continue clearing ketones (in DKA) without causing hypoglycemia or too-rapid a glucose drop. Step 5 — IDENTIFY AND TREAT the precipitating cause (infection is most common — obtain cultures, start antibiotics as ordered). Ongoing monitoring: hourly blood glucose, serum electrolytes (especially potassium), arterial blood gases (in DKA — pH monitoring), urine output, vital signs, neurological status, cardiac monitoring.

Examples

Classic DKA: young Type 1 patient, missed insulin during illness, Kussmaul breathing (deep/rapid — compensating for metabolic acidosis by blowing off CO2), fruity breath (exhaled ketones), elevated ketones, low pH and bicarbonate. The K+ of 5.0 is deceptive — it looks normal but total body K+ is depleted; insulin will drop it rapidly. This is the #1 NLE electrolyte trap in DKA management.

Scenario

A 19-year-old Type 1 DM patient is brought to the ER after 2 days of vomiting and diarrhea (had stopped taking insulin because she was not eating). She is confused, breathing deeply and rapidly, and her breath smells fruity. Labs: glucose 480 mg/dL, pH 7.28, HCO3 12 mEq/L, ketones 3+ in urine, K+ 5.0 mEq/L.

Solution

This is DKA. Priority nursing actions in order: (1) Establish large-bore IV access and begin IV 0.9% Normal Saline rapidly (1 L over first hour). (2) Prepare and begin IV Regular insulin drip as ordered. (3) Monitor potassium closely — K+ is currently 5.0 (appears normal/slightly high) but WILL DROP once insulin is given. Do not begin insulin without a potassium replacement plan. (4) Continuous cardiac monitoring. (5) Hourly glucose checks. (6) Identify and treat precipitating cause (vomiting/diarrhea + missed insulin). (7) Add dextrose to IV fluids when glucose reaches ~200–250 mg/dL.

Classic HHNS: elderly Type 2 patient, gradual onset over days (caregiver not noticing subtle deterioration), glucose >1,000, elevated osmolality (>320), absent ketones, near-normal pH. The elderly with dementia are a HIGH-RISK group because they cannot communicate thirst, leading to extreme dehydration. Higher mortality than DKA. The NLE may ask what distinguishes this from DKA — the absence of ketones and acidosis, the much higher glucose, and the gradual onset.

Scenario

An 72-year-old Type 2 DM patient with dementia is brought to the ER in a comatose state. His daughter says he had been 'confused and not drinking well' for 5 days. Labs: glucose 1,100 mg/dL, serum osmolality 355 mOsm/kg, pH 7.38, ketones absent, BUN 60 mg/dL.

Solution

This is HHNS. Management: (1) Aggressive IV fluid resuscitation with 0.9% NS (profound dehydration, correcting osmolality must be done gradually to avoid cerebral edema). (2) IV Regular insulin drip at a lower rate than DKA to gradually lower glucose. (3) Potassium replacement as levels may fall with insulin. (4) Neurological monitoring every hour. (5) Investigate and treat the precipitating cause (likely dehydration, infection, or medication non-adherence in the context of dementia).

Applications

Triage priority: both DKA and HHNS are medical emergencies — prioritize airway, breathing, circulation, then glucose correction (Maslow: physiologic safety first).
ICU-level nursing: continuous cardiac monitoring (hypokalemia can cause fatal arrhythmias — flat T waves, U waves, prolonged QT on ECG), hourly glucose monitoring, strict I&O, neuro assessments.
Anticipate the potassium drop — before starting insulin, ensure IV potassium replacement is ordered and ready.
NANDA nursing diagnoses: 'Deficient Fluid Volume,' 'Risk for Electrolyte Imbalance,' 'Disturbed Thought Processes,' 'Risk for Injury,' 'Ineffective Breathing Pattern' (DKA Kussmaul).
Prevention teaching for DM patients: 'sick day rules' — never stop insulin during illness, monitor glucose and ketones more frequently, stay hydrated, and know when to seek emergency care.
In Philippine government hospitals (PhilHealth coverage), nurses must be competent in DKA/HHNS protocol management and clear documentation under RA 9173 accountability standards.

Misconceptions

MISCONCEPTION: 'Giving insulin is always the first priority in DKA/HHNS.' TRUTH: IV FLUIDS (Normal Saline) come FIRST. Insulin without fluid resuscitation can cause circulatory collapse from already-depleted fluid volume.
MISCONCEPTION: 'If the patient's potassium is high (5.0), I don't need to worry about potassium.' TRUTH: In DKA, apparent normokalemia or hyperkalemia masks total body potassium depletion. Insulin will rapidly drive K+ into cells, causing life-threatening hypokalemia — always monitor and prepare to replace.
MISCONCEPTION: 'HHNS is less dangerous than DKA because there is no acidosis.' TRUTH: HHNS has HIGHER MORTALITY than DKA. Profound dehydration, extreme glucose (>1,000 mg/dL possible), and severe neurological deterioration make HHNS extremely dangerous.
MISCONCEPTION: 'Any insulin can be used in the IV drip for DKA management.' TRUTH: ONLY Regular (short-acting) insulin is given IV. NPH, glargine, and other insulins cannot be given intravenously.
MISCONCEPTION: 'Once the glucose normalizes, the insulin drip should be stopped immediately in DKA.' TRUTH: In DKA, the insulin drip is continued until the KETOACIDOSIS is resolved (pH normalized, bicarbonate recovered) — not just until glucose normalizes. Dextrose is added to the IV fluids to maintain glucose at 150–200 mg/dL while insulin continues to clear ketones.

Related Concepts

Insulin pharmacology (only Regular insulin given IV)
Electrolyte imbalances (hypokalemia in DKA/HHNS)
Acid-base balance (metabolic acidosis in DKA)
Fluid volume deficit (profound dehydration in HHNS)
Cardiac monitoring (ECG changes from hypokalemia)
Cerebral edema risk (too-rapid glucose correction)

Common Exam Questions

Example

A patient has blood glucose of 850 mg/dL, serum osmolality of 340, absent ketones, and pH of 7.40. This presentation is consistent with: HHNS (not DKA, because no ketones and near-normal pH).

Approach

Compare: DKA = Type 1, ketones + acidosis, Kussmaul breathing, fruity breath, glucose 250–600, rapid onset. HHNS = Type 2, no ketones, near-normal pH, profound dehydration, glucose >600, gradual onset.

Question Type

DKA vs. HHNS Differentiation

Example

A patient with DKA presents with glucose 450 mg/dL and signs of severe dehydration. The FIRST nursing action is: initiate IV 0.9% Normal Saline infusion (fluid resuscitation before insulin).

Approach

IV fluids ALWAYS come first in both DKA and HHNS — before insulin. This corrects dehydration, lowers glucose by dilution, and restores perfusion.

Question Type

Priority Nursing Action (First Action)

Example

A DKA patient's initial potassium is 4.8 mEq/L. After starting IV regular insulin, the nurse should monitor the patient MOST closely for: Hypokalemia (K+ will shift into cells as insulin works — risk of cardiac arrhythmias).

Approach

The NLE may show a patient with DKA whose initial K+ is 5.5 mEq/L and ask what the nurse should monitor for — the answer is hypokalemia after insulin therapy, not hyperkalemia.

Question Type

Potassium Monitoring in DKA

Example

A DKA patient is breathing very rapidly and deeply. The nurse understands this is caused by: metabolic acidosis stimulating the respiratory center to blow off CO2 and raise blood pH (respiratory compensation for metabolic acidosis).

Approach

Kussmaul breathing (deep, rapid, labored) is the body's attempt to compensate for metabolic acidosis by increasing CO2 exhalation. This is not hyperventilation from anxiety — it is a physiologic response.

Question Type

DKA Respiratory Compensation

Key Points To Remember

DKA: Type 1, glucose 250–600, KETONES + ACIDOSIS, Kussmaul respirations, fruity breath, onset in HOURS.
HHNS: Type 2, glucose >600 (up to >1,000), NO ketones/acidosis, pH near normal, PROFOUND dehydration, high osmolality (>320), severe neuro changes, onset over DAYS.
HHNS has HIGHER MORTALITY than DKA despite no acidosis — due to profound dehydration and extreme glucose elevation.
Management priority order: (1) IV Normal Saline FIRST → (2) Regular insulin IV → (3) Potassium replacement.
POTASSIUM TRAP: serum K may be normal/high at presentation (acidosis pushes K out of cells), but DROPS dangerously after insulin given (insulin drives K into cells) → monitor K and ECG; replace before/with insulin.
Add DEXTROSE to IV fluids when glucose reaches ~200–250 mg/dL to prevent hypoglycemia while continuing insulin to clear ketones.
ONLY Regular insulin is given IV — never NPH or long-acting insulin.
Lower glucose GRADUALLY (~50–75 mg/dL/hr) — too rapid a drop causes cerebral edema (especially dangerous in pediatric DKA).

Chronic Complications of Diabetes Mellitus

Chronic DM complications develop over years of poor glycemic control and represent the long-term consequences of sustained hyperglycemia on blood vessels and nerves. They are divided into MICROVASCULAR (affecting small blood vessels) and MACROVASCULAR (affecting large blood vessels) complications. Understanding these complications drives the rationale for strict blood glucose control (HbA1c <7%). MICROVASCULAR COMPLICATIONS (small vessel disease — directly related to glucose control): 1. DIABETIC RETINOPATHY: Damage to the small blood vessels of the retina. Microaneurysms, hemorrhages, neovascularization, and retinal detachment occur progressively. DIABETIC RETINOPATHY IS THE LEADING CAUSE OF ADULT BLINDNESS (a frequently tested fact). The patient may be asymptomatic for years before vision loss occurs. Nursing intervention: annual (or more frequent) dilated eye examinations by an ophthalmologist; tight glucose AND blood pressure control; early referral for laser photocoagulation therapy if neovascularization is detected. 2. DIABETIC NEPHROPATHY: Damage to the glomeruli of the kidneys, impairing their filtering function. Progresses from microalbuminuria → macroalbuminuria → declining GFR → end-stage renal disease (ESRD). DIABETIC NEPHROPATHY IS THE LEADING CAUSE OF ESRD (end-stage renal disease requiring dialysis) — another heavily tested fact. Nursing: monitor for microalbuminuria (earliest sign), blood pressure control, ACE inhibitors or ARBs are FIRST-LINE agents (renoprotective, reduce proteinuria), avoid nephrotoxic agents (NSAIDs, contrast dye), and dietary protein modification. 3. DIABETIC NEUROPATHY: Nerve damage from sustained hyperglycemia. Types: - Peripheral neuropathy (most common): damage to sensory nerves in the extremities, especially the feet. Symptoms: numbness, tingling (paresthesias), burning pain, and — most dangerously — LOSS OF PROTECTIVE SENSATION. When patients cannot feel pain, injury to the feet goes unnoticed → infections → ulcers → gangrene → AMPUTATION. THIS IS WHY DIABETIC FOOT CARE IS PARAMOUNT. - Autonomic neuropathy: damage to nerves controlling involuntary body functions. Manifestations include: * Gastroparesis (delayed gastric emptying) → nausea, bloating, unpredictable glucose absorption after meals. * Orthostatic hypotension (drop in BP when standing) → dizziness, falls. * Erectile dysfunction. * Bladder dysfunction (neurogenic bladder). * Hypoglycemia unawareness (autonomic signals of hypoglycemia blunted → patient has no warning before severe hypoglycemia). * Silent myocardial infarction (cannot feel chest pain from MI due to autonomic neuropathy — MI may present as only fatigue or dyspnea). MACROVASCULAR COMPLICATIONS (large vessel disease — atherosclerosis accelerated by hyperglycemia, dyslipidemia, and hypertension): 1. CORONARY ARTERY DISEASE (CAD): The most common macrovascular complication. CARDIOVASCULAR DISEASE IS THE LEADING CAUSE OF DEATH IN DIABETES — the most important macrovascular fact to memorize. 2. CEREBROVASCULAR DISEASE: Increased risk of stroke. 3. PERIPHERAL VASCULAR DISEASE (PVD): Reduced blood flow to the lower extremities → intermittent claudication, poor wound healing, gangrene. Combines with neuropathy to create the high-risk 'diabetic foot.' DIABETIC FOOT CARE (a major NLE teaching topic — expect scenario questions): With peripheral neuropathy (cannot feel pain) + peripheral vascular disease (poor blood flow to heal) + impaired immunity (poor wound healing), the diabetic foot is at extreme risk for ulceration and amputation. Patient education MUST include: - INSPECT feet DAILY (use a mirror for the sole of the feet if needed; have a family member help if vision is impaired) - WASH and DRY feet daily (especially BETWEEN THE TOES — moisture between toes promotes fungal infection and skin breakdown) - Wear PROPERLY FITTING CLOSED-TOE SHOES at all times — NEVER go barefoot (cannot feel injury from stepping on objects) - Cut toenails STRAIGHT ACROSS (not rounded at the corners — prevents ingrown nails) - NEVER use heating pads, hot water bottles, or hot water soaks (neuropathy means the patient cannot feel burns — thermal injuries are common) - Report any wound, blister, or discoloration to the healthcare provider IMMEDIATELY — what seems minor can rapidly progress to serious infection - Apply moisturizing lotion to the soles and dorsum of feet (NOT between the toes) to prevent cracking - Wear clean, dry, seamless cotton socks daily

Examples

The patient did not feel the blister forming — loss of protective sensation from peripheral neuropathy. Even a minor blister can progress to a deep ulcer, osteomyelitis, or gangrene in a diabetic patient with poor circulation and impaired immunity. The NLE frequently tests nursing priorities in diabetic foot wound scenarios — always assess first, protect the wound, and facilitate specialist referral.

Scenario

A 55-year-old patient with a 20-year history of Type 2 DM presents with a painless blister on his right great toe. He reports he did not notice it until his wife saw it during a foot bath. He also complains of numbness and tingling in both feet.

Solution

This is a classic presentation of peripheral neuropathy with a high-risk diabetic foot wound. Nursing priorities: (1) Assess the blister (size, depth, surrounding tissue color and temperature, signs of infection — redness, warmth, drainage, odor). (2) Do NOT aspirate or pop the blister (increases infection risk) — cover with a sterile, non-compressive dressing as ordered. (3) Assess vascular status (pedal pulses, capillary refill, ABI). (4) Refer to physician/wound care specialist. (5) Provide intensive foot care education. (6) Assess HbA1c and glycemic control status.

Autonomic neuropathy is a devastating and underappreciated complication. Orthostatic hypotension and hypoglycemia unawareness are both safety risks requiring nursing intervention. The NLE may ask the nurse to identify the complication type and the appropriate safety intervention — fall prevention and increased glucose monitoring are key.

Scenario

A patient with long-standing Type 1 DM reports feeling dizzy and nearly fainting every time she stands up from sitting. She also reports that her blood sugar recently dropped to 45 mg/dL without her feeling any of the usual warning signs (no shakiness or sweating).

Solution

These are manifestations of autonomic neuropathy: orthostatic hypotension (dizzy when standing) and hypoglycemia unawareness (loss of adrenergic warning signs due to autonomic nerve damage). Nursing interventions: (1) Implement fall prevention protocol — teach patient to rise slowly, sit at the edge of the bed first, use call bell. (2) Increase frequency of blood glucose monitoring (since she cannot feel hypoglycemia symptoms, she must rely on external monitoring). (3) Adjust glucose target slightly higher (to reduce hypoglycemia risk, as she has no warning signs). (4) Educate on hypoglycemia unawareness and the importance of continuous glucose monitoring (CGM) if available.

Applications

Include foot inspection in every physical assessment of a diabetic patient — a 'routine' visit could reveal a previously unnoticed wound.
Apply NANDA diagnoses: 'Impaired Tissue Integrity' (neuropathic ulcer), 'Risk for Peripheral Neurovascular Dysfunction,' 'Deficient Knowledge' (foot care), 'Risk for Falls' (orthostatic hypotension).
In Philippine barangay health settings, community nurses conduct diabetes clinic sessions where foot care education and annual foot inspections (monofilament testing for protective sensation) are standard care.
Teach patients with diabetic nephropathy about low-sodium, low-protein, high-quality protein diets and the importance of blood pressure control (<130/80 mmHg in diabetes) to slow nephropathy progression.
Educate patients on annual dilated eye exams — many Filipino patients with Type 2 DM present late with advanced retinopathy because asymptomatic early stages were missed.
Emphasize that smoking cessation is critical in diabetic patients — smoking accelerates ALL macrovascular complications.

Misconceptions

MISCONCEPTION: 'Diabetic patients feel pain from foot ulcers, so they will report it promptly.' TRUTH: Peripheral neuropathy causes LOSS OF PROTECTIVE SENSATION — patients often do not feel foot injuries at all. This is why daily foot inspection by the patient (or a caregiver) is essential.
MISCONCEPTION: 'If a diabetic patient has a normal serum creatinine, the kidneys are fine.' TRUTH: Microalbuminuria (small amounts of albumin in the urine) is the EARLIEST sign of nephropathy — it can be detected years before creatinine rises. Annual urine microalbumin testing is essential.
MISCONCEPTION: 'Only Type 1 diabetic patients get complications.' TRUTH: Both Type 1 and Type 2 patients develop micro- and macrovascular complications. Tight glucose control is essential for BOTH types.
MISCONCEPTION: 'Moisturizing cream should be applied between the toes to prevent dryness.' TRUTH: Do NOT apply lotion BETWEEN the toes — moisture trapped in interdigital spaces promotes fungal infections (tinea pedis) and skin maceration, increasing infection risk.
MISCONCEPTION: 'Diabetic patients will feel chest pain if they have a heart attack.' TRUTH: Autonomic neuropathy causes 'silent MI' — diabetic patients may not experience typical chest pain. MI may present as only fatigue, dyspnea, or nausea. Any unexplained symptoms in a diabetic patient warrant cardiac evaluation.

Related Concepts

Hypertension management in DM (blood pressure control protects kidneys and heart)
ACE inhibitors/ARBs in nephropathy
Wound care and infection prevention
Fall prevention (autonomic neuropathy, orthostatic hypotension)
Hypoglycemia unawareness (autonomic neuropathy complication)
Smoking cessation (macrovascular risk reduction)

Common Exam Questions

Example

Diabetic nephropathy is the leading cause of: End-stage renal disease (ESRD) requiring dialysis.

Approach

Memorize the 'leading cause' facts: retinopathy = leading cause of adult blindness; nephropathy = leading cause of ESRD; cardiovascular disease = leading cause of death in DM.

Question Type

Identification of Leading Cause

Example

A diabetic patient says 'I soak my feet in hot water every night to relax them.' The nurse's best response is: 'You should avoid hot water soaks because diabetic neuropathy reduces your ability to feel burns, which can cause serious injury without you realizing it. Use warm (not hot) water and test the temperature with your elbow or a thermometer.'

Approach

Look for the MOST important or the INCORRECT teaching point. Common incorrect answers: using heating pads, going barefoot, cutting nails in a curve, soaking feet in hot water.

Question Type

Foot Care Teaching Priority

Example

During a home visit, the community nurse assesses a diabetic patient's feet and finds: (a) mild calluses, (b) a 2 cm wound on the heel that smells foul with surrounding redness, (c) mild skin dryness, (d) slightly long toenails. The nurse's PRIORITY concern is: (b) the infected wound — requires immediate physician referral and wound care.

Approach

Among multiple assessment findings in a DM scenario, identify which requires IMMEDIATE action. An unnoticed wound, absent pedal pulses, or signs of infection are high priorities.

Question Type

Priority Assessment Finding

Key Points To Remember

Microvascular complications: retinopathy (leading cause of adult blindness), nephropathy (leading cause of ESRD), neuropathy (peripheral + autonomic).
Macrovascular complications: CAD, cerebrovascular disease, peripheral vascular disease — CARDIOVASCULAR DISEASE is the leading cause of DEATH in DM.
ACE inhibitors/ARBs: first-line renoprotective agents in diabetic nephropathy — reduce proteinuria and slow GFR decline.
Peripheral neuropathy: loss of protective sensation → unnoticed injury → ulcers → amputation. Prevention = foot care.
Autonomic neuropathy: gastroparesis (unpredictable glucose absorption), orthostatic hypotension (fall risk), silent MI (no chest pain), hypoglycemia unawareness.
Foot care essentials: inspect daily, no barefoot, no heating pads, cut nails straight, dry between toes, report wounds immediately.
Tight glycemic control (HbA1c <7%) is the primary prevention for ALL microvascular complications.
Microalbuminuria is the earliest detectable sign of diabetic nephropathy — monitor urine annually.

Practice Problems

Metformin must be held around contrast procedures because contrast dye can cause contrast-induced nephropathy, which impairs metformin clearance → metformin accumulates → lactic acidosis. With already-elevated creatinine, the risk is compounded. This is a HIGH-YIELD NLE scenario combining pharmacology, procedural nursing, and clinical safety judgment. Note: glipizide (sulfonylurea) can cause hypoglycemia when the patient is NPO — always clarify insulin/OHA orders before procedures.

Problem

A 45-year-old female patient with Type 2 DM is scheduled for a CT scan with contrast. She takes metformin 500 mg BID and glipizide 5 mg once daily. Her serum creatinine is 1.8 mg/dL (slightly elevated). What are the nursing priorities BEFORE the procedure?

Solution

Priority nursing actions: (1) HOLD metformin 24–48 hours BEFORE the CT scan with contrast — document and notify the physician. (2) Inform the physician about the elevated creatinine (indicates pre-existing renal impairment, which increases lactic acidosis risk with metformin if contrast-induced nephropathy occurs). (3) Continue glipizide as ordered but monitor glucose — if the patient will be NPO, clarify whether to hold or adjust glipizide (risk of hypoglycemia when not eating). (4) Ensure adequate hydration before and after the procedure (IV fluids as ordered) to protect renal function. (5) Metformin should NOT be resumed until renal function is confirmed stable 48 hours post-procedure.

This problem tests the 'potassium trap' — the highest-yield concept in DKA nursing management. The initial K+ was 5.8 (appeared high/normal) because acidosis had pushed K+ out of cells. After 3 hours of insulin therapy, K+ shifted back into cells, dropping to 3.1 — a dangerous hypokalemic level. Failure to anticipate and manage this can result in ventricular fibrillation and cardiac arrest. The NLE expects candidates to recognize that K+ monitoring and replacement is a co-management priority with insulin therapy in DKA.

Problem

A nurse is caring for a 22-year-old Type 1 DM patient in DKA. Labs at 8 AM: glucose 510 mg/dL, K+ 5.8 mEq/L, pH 7.22, HCO3 10 mEq/L. IV Normal Saline is running. The physician orders IV Regular insulin drip to begin. At 11 AM (3 hours later), the patient's glucose is 300 mg/dL, K+ is 3.1 mEq/L. What is the PRIORITY nursing concern at 11 AM, and what actions should the nurse take?

Solution

PRIORITY CONCERN at 11 AM: HYPOKALEMIA (K+ 3.1 mEq/L — below normal range of 3.5–5.0 mEq/L). This is the classic potassium drop in DKA after insulin administration. Priority nursing actions: (1) Notify the physician IMMEDIATELY about the potassium level of 3.1 mEq/L. (2) Place the patient on continuous cardiac monitoring — hypokalemia causes dangerous arrhythmias (look for flattened T waves, U waves, prolonged QT on ECG). (3) Administer potassium replacement IV as ordered — ensure adequate urine output before infusing potassium. (4) Continue to monitor glucose hourly — at 300 mg/dL, continue the insulin drip but prepare to add dextrose to IV fluids as glucose approaches 200–250 mg/dL. (5) Monitor for signs of hypokalemia: muscle weakness, leg cramps, fatigue, palpitations. (6) Recheck electrolytes as ordered.

The sequence — 'Air into NPH first, draw clear (Regular) before cloudy (NPH)' — is one of the most frequently tested nursing procedures in the NLE. Rationale: injecting air into the NPH first prevents contamination of the regular vial (if regular is drawn first without the air-injection sequence, and then NPH air is injected, NPH could be forced back into the regular vial via backflow). Drawing regular first prevents NPH from contaminating the pure regular vial, which would alter future doses. The abdomen is the preferred injection site for consistent absorption.

Problem

A patient is prescribed the following insulin regimen: NPH 20 units and Regular 10 units subcutaneously every morning before breakfast. Describe the CORRECT preparation procedure, including the mixing sequence.

Solution

Correct procedure: (1) Wash hands and gather supplies. (2) Inspect both insulin vials — check clarity (Regular is clear, NPH is cloudy), expiration dates, and ensure no particulate matter in Regular vial. (3) Gently ROLL the NPH vial between palms to resuspend (do not shake). (4) Clean both vial tops with alcohol swabs. (5) Inject 20 units of AIR into the NPH (cloudy) vial — do NOT draw insulin yet; withdraw needle. (6) Inject 10 units of AIR into the Regular (clear) vial. (7) WITHDRAW 10 units of REGULAR (clear) insulin from the regular vial. (8) WITHDRAW 20 units of NPH (cloudy) insulin — total = 30 units in syringe. (9) Administer subcutaneously in the abdomen (preferred site) using correct technique. (10) Document administration and observe patient's meal readiness.

The NLE differentiator: LOW 2–3 AM glucose = Somogyi (rebound) → REDUCE insulin. NORMAL or HIGH 2–3 AM glucose = Dawn phenomenon (normal hormone surge) → ADJUST/INCREASE insulin. Many nurses incorrectly increase insulin when faced with morning hyperglycemia, which would worsen the nocturnal hypoglycemia in Somogyi phenomenon — a dangerous error. The correct approach requires first determining the cause by checking the overnight glucose.

Problem

A 68-year-old patient with Type 2 DM has been having high blood glucose readings every morning (around 220–250 mg/dL) for the past two weeks. The nurse monitors his glucose at 2 AM for three nights and finds the values are: Night 1: 58 mg/dL; Night 2: 65 mg/dL; Night 3: 61 mg/dL. What phenomenon is occurring, and what is the appropriate nursing/medical intervention?

Solution

This is the SOMOGYI PHENOMENON (rebound morning hyperglycemia from nocturnal hypoglycemia). The 2–3 AM glucose values are consistently LOW (<70 mg/dL), confirming nighttime hypoglycemia. The body responds to nocturnal hypoglycemia by releasing counter-regulatory hormones (glucagon, epinephrine, cortisol, growth hormone), which stimulate hepatic glucose release, causing rebound morning hyperglycemia. Interventions: (1) REDUCE the evening insulin dose (the physician must adjust the order). (2) Add a BEDTIME SNACK containing complex carbohydrates and protein (e.g., crackers with peanut butter, milk and bread) to prevent the nocturnal glucose dip. (3) Continue monitoring glucose at 2–3 AM to evaluate response to the intervention. (4) Document findings and report to the physician. (5) Reassess the morning glucose after the intervention to confirm resolution.

This scenario reflects the Philippine community health context where nurses (NCM 104) conduct health education at barangay level. Diabetic foot education is a TOP NLE teaching priority because foot complications leading to amputation are preventable with proper care. The husband's habit of hot water soaks is a common home remedy in Filipino culture that becomes dangerous with neuropathy. The nurse must be culturally sensitive yet clinically firm in correcting this practice. Under RA 9173, nurses are mandated to provide health education as a core nursing responsibility.

Problem

During a community health visit (barangay health center), a nurse is conducting a diabetes education session. A participant asks: 'My husband soaks his feet in hot water every night because his feet feel numb and cold. Is that okay?' How should the nurse respond, and what comprehensive foot care teaching should be provided?

Solution

The nurse responds: 'No, that is not safe for your husband. Because his feet feel numb, he cannot feel if the water is too hot and can get burned without knowing it. This is called diabetic neuropathy — a nerve problem from diabetes that removes the feeling of pain and temperature. Burns on diabetic feet can become very serious infections. Please stop the hot water soaks immediately.' Comprehensive foot care teaching: (1) INSPECT feet DAILY for cuts, blisters, redness, or swelling — use a mirror for the sole, or ask a family member to help. (2) WASH feet daily with mild soap and lukewarm (NOT hot) water — test temperature with elbow, not fingers. (3) DRY thoroughly, especially BETWEEN the toes. (4) Apply moisturizing lotion to tops and soles (not between toes). (5) Wear CLEAN, DRY, SEAMLESS COTTON SOCKS and properly fitting CLOSED-TOE SHOES at all times — never barefoot. (6) Cut toenails STRAIGHT ACROSS — never curved or too short. (7) NEVER use heating pads, hot water bottles, or electric blankets on feet. (8) Report ANY wound, blister, redness, or change in foot color or temperature to the healthcare provider IMMEDIATELY. (9) Regular professional foot exams at the health center.

Exam Preparation Tips

MEMORIZE INSULIN ONSET-PEAK-DURATION TABLE COLD: Create a mnemonic or flashcard for each category. The NLE will test this in multiple ways — directly (which insulin peaks at 6–12 hours?) and indirectly (when should the nurse monitor for hypoglycemia after NPH?). Know that ONLY Regular insulin is given IV, NPH is the ONLY cloudy insulin, and glargine is PEAKLESS and NEVER mixed.
LEARN THE DIAGNOSTIC GLUCOSE VALUES BY HEART: Fasting ≥126 mg/dL = diabetes, <100 = normal, 100–125 = prediabetes. Random ≥200 with symptoms = diabetes. HbA1c ≥6.5% = diabetes, target <7%. OGTT 2-hr ≥200 = diabetes. The NLE will present borderline values — know which values confirm, suspect, or rule out diabetes.
MASTER THE DKA vs. HHNS COMPARISON TABLE: Practice filling in a blank comparison table from memory. The key differentiators are: ketones (DKA has them, HHNS does not), pH (DKA acidic, HHNS near-normal), glucose levels (DKA 250–600, HHNS >600), onset speed (DKA hours, HHNS days), and patient type (DKA = Type 1, HHNS = Type 2). This comparison appears in ALMOST EVERY NLE exam.
PRIORITIZE THE POTASSIUM TRAP IN DKA: This is THE classic wrong-answer trap in DKA management. Initial K+ may look normal or high (because acidosis pushes K out of cells). After insulin, K+ drops dangerously (shifts back into cells). Always: monitor K+, prepare replacement, and do not give insulin if K+ is critically low. Practice questions with serum K+ values before and after insulin.
APPLY THE RULE OF 15 AUTOMATICALLY FOR HYPOGLYCEMIA: When you see a conscious patient with glucose <70, the answer is 15 g fast carbs, wait 15 min, recheck, repeat. When unconscious: IV D50 or IM glucagon — NOTHING by mouth. Practice recognizing the conscious vs. unconscious distinction in scenarios.
USE THE SKIN ASSESSMENT TRICK: Hypoglycemia = COLD, CLAMMY, DIAPHORETIC skin (from adrenergic response). Hyperglycemia = WARM, DRY, FLUSHED skin (from dehydration). This single assessment finding can help you differentiate two completely opposite emergencies. Many NLE questions include skin description — use it.
REMEMBER THE 'LEADING CAUSE' FACTS: Retinopathy = leading cause of adult BLINDNESS. Nephropathy = leading cause of ESRD. Cardiovascular disease = leading cause of DEATH in DM. These facts appear directly in NLE multiple-choice items with options asking you to choose between the complications.
PRACTICE SOMOGYI vs. DAWN SCENARIO QUESTIONS: The NLE will give you a morning hyperglycemia scenario and ask for the intervention. Always mentally check: 'What is the 2–3 AM glucose?' If LOW → Somogyi → REDUCE insulin. If NORMAL/HIGH → Dawn → ADJUST/INCREASE insulin. Never increase insulin without knowing the overnight glucose in a patient with morning highs.
DRILL THE MIXING SEQUENCE: 'Air into NPH (cloudy) FIRST, then air into Regular (clear). Draw CLEAR (regular) FIRST, then draw CLOUDY (NPH).' Practice writing or saying this sequence repeatedly. The NLE may present the steps out of order and ask which step is FIRST or which is INCORRECT.
FOR DRUG QUESTIONS, FOCUS ON METFORMIN + CONTRAST DYE: The scenario of a diabetic patient scheduled for a contrast procedure is extremely common in the NLE. The priority action is ALWAYS to hold metformin. Know why: contrast → kidney damage → metformin accumulation → lactic acidosis. Also remember: metformin DOES NOT cause hypoglycemia alone.
FOOT CARE WRONG ANSWERS: The NLE often presents foot care teaching scenarios and asks 'which statement by the patient indicates a need for further teaching?' Wrong (incorrect) patient statements include: 'I soak my feet in hot water,' 'I go barefoot at home,' 'I apply lotion between my toes,' 'I cut my nails in a curve,' 'I use a heating pad for my foot pain.' Any of these indicates INCORRECT understanding — and therefore the NLE answer.
USE NANDA DIAGNOSES IN PRIORITIZATION QUESTIONS: In 'which action is priority?' questions, use Maslow's hierarchy: physiologic safety first. In DKA: Deficient Fluid Volume and Disturbed Gas Exchange (Kussmaul) are top priorities. In hypoglycemia: Risk for Injury. In chronic DM: Deficient Knowledge and Impaired Tissue Integrity for foot ulcers. Practice mapping clinical scenarios to the correct NANDA diagnosis.
STUDY IN CLINICAL GROUPS: NLE preparation for DM is most effective when practiced in small groups — test each other on insulin peaks, DKA vs. HHNS findings, and foot care teaching points. Explaining concepts aloud (peer teaching) consolidates memory better than passive reading.
REVIEW PHILIPPINE CONTEXT: Know that in Philippine public health settings, metformin is a core drug in the essential medicines list, diabetes is a PhilHealth Z-benefit covered condition, and community nurses at barangay health centers conduct diabetes screening and education. NLE scenarios set in RHU, barangay health centers, or community settings are testing your NCM 104/105 competencies alongside clinical knowledge.

Loading diagram…

In summary

Diabetes Mellitus is one of the most clinically significant and heavily examined topics in the Philippine NLE — and for good reason. As a nurse, your knowledge of DM pathophysiology, insulin pharmacology, acute emergency management, and chronic complication prevention directly determines patient safety. A nurse who confuses DKA with hypoglycemia, gives the wrong insulin intravenously, or fails to anticipate hypokalemia after insulin therapy can cause irreversible harm. Under RA 9173, you are legally and professionally accountable for competent, safe nursing care. To summarize the highest-yield NLE points from this chapter: Type 1 DM always needs insulin and is prone to DKA; Type 2 DM is managed with oral agents and is prone to HHNS. Insulin peaks determine hypoglycemia risk — Regular peaks at 2–4 hours, NPH at 6–12 hours, rapid-acting at 30 minutes to 1.5 hours, and glargine is peakless. Only Regular insulin is given intravenously. Draw clear before cloudy when mixing. For hypoglycemia in the conscious patient, use the Rule of 15; for the unconscious patient, IV D50 or IM glucagon — never anything by mouth. In DKA and HHNS, give IV Normal Saline FIRST, then insulin, then watch for the potassium drop. Add dextrose when glucose reaches 200–250 mg/dL. In the morning hyperglycemia scenarios, check the 2–3 AM glucose: low means Somogyi (reduce insulin), normal/high means Dawn (adjust insulin). For chronic complications: retinopathy causes blindness, nephropathy causes ESRD, and cardiovascular disease is the leading cause of death. Protect the diabetic foot — no heating pads, no barefoot, no hot water soaks, inspect daily. In the Philippine healthcare system, where millions of Filipinos live with diabetes and access to specialist care may be limited, the nurse is often the primary educator, care coordinator, and safety net. Master this chapter — not just to pass the NLE, but to become the nurse your future patients deserve. Maging handa, maging kompetente, maging ligtas.

Previous chapter

Adrenal Disorders

Ready to practise for the NLE 2026?

Super Tutor's AI review plan adapts to your weak areas and builds a weekly practice schedule around your target NLE exam date.

Start free See the full NLE guide NLE preparation guide

← Back to Endocrine & Metabolic Nursing hub